Caviid betaherpesvirus 2

From WikiMD's WELLNESSPEDIA

A virus affecting guinea pigs


Caviid betaherpesvirus 2 (CavHV-2) is a species of virus in the genus Cytomegalovirus, which is part of the subfamily Betaherpesvirinae within the family Herpesviridae. This virus primarily infects guinea pigs, and it is used as a model organism for studying cytomegalovirus infections in humans.

Virology[edit]

Caviid betaherpesvirus 2 is a double-stranded DNA virus with a large genome typical of the Herpesviridae family. Like other betaherpesviruses, it has a slow replication cycle and establishes lifelong latency in the host. The virus can reactivate under certain conditions, leading to viral shedding and potential transmission.

Pathogenesis[edit]

In guinea pigs, CavHV-2 can cause a range of symptoms, although many infections are asymptomatic. When symptoms do occur, they may include respiratory distress, weight loss, and lethargy. The virus is transmitted through direct contact with infected bodily fluids, such as saliva or urine.

Research and Model Organism[edit]

Caviid betaherpesvirus 2 is extensively used in research as a model for human cytomegalovirus (HCMV) infections. The guinea pig model is particularly valuable because it allows for the study of congenital infections, which are a significant concern in human health. Researchers use this model to study viral pathogenesis, immune responses, and potential vaccine candidates.

Diagnosis and Treatment[edit]

Diagnosis of CavHV-2 infection in guinea pigs can be performed using polymerase chain reaction (PCR) to detect viral DNA, as well as serological tests to identify antibodies against the virus. There is currently no specific antiviral treatment for CavHV-2, and management focuses on supportive care and prevention of transmission.

Also see[edit]


Herpesviridae
Herpesviridae virion
Herpesviridae virion
Taxonomy
Kingdom Virus
Order Herpesvirales
Family Herpesviridae
Genera
Notable Species
Related Topics


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Caviid_betaherpesvirus_2&oldid=6501032"